As of the latest Form 4 filed Apr 24, 2026.
What Organogenesis Holdings Inc insiders — officers, directors and 10% owners — have bought and sold in their own stock, straight from their SEC Form 4 filings. Values are shares × the reported transaction price where both are disclosed.
Buys plotted up, sells down; bar height is the disclosed dollar value (shares × reported price). Our Form 4 history is only complete from mid-2026, so early months are sparse — the series fills in as more filings land. Open-market purchases and sales only.
Newest filing first — the 12 most recent filings for ORGO.
| Filed | Trade date | Insider | Transaction | Shares | Price | Value | 10b5-1 | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-04-24 | 2025-01-10 | Grow Brian Chief Commercial Officer | MExercise | +958.00 | $1.24 | $1.19K | No | Form 4 ↗ |
| 2025-12-18 | 2025-12-16 | NUSSDORF GLENN H Director | SSale | −200K | $5.14 | $1.03M | No | Form 4 ↗ |
| 2025-11-26 | 2025-11-26 | NUSSDORF GLENN H Director | SSale | −188K | $5.29 | $994K | No | Form 4 ↗ |
| 2025-11-26 | 2025-11-25 | NUSSDORF GLENN H, Director | SSale | −12.0K | $5.30 | $63.8K | No | Form 4 ↗ |
| 2025-11-26 | 2025-11-24 | NUSSDORF GLENN H, Director | SSale | −100K | $5.34 | $534K | No | Form 4 ↗ |
| 2025-11-03 | 2025-06-10 | NUSSDORF GLENN H Director | SSale | −18.6K | $3.56 | $66.3K | No | Form 4 ↗ |
| 2025-11-03 | 2025-06-09 | NUSSDORF GLENN H, Director | SSale | −4.16K | $3.50 | $14.5K | No | Form 4 ↗ |
| 2025-11-03 | 2025-05-15 | NUSSDORF GLENN H, Director | PPurchase | +107K | $2.99 | $321K | No | Form 4 ↗ |
| 2025-11-03 | 2025-05-14 | NUSSDORF GLENN H, Director | PPurchase | +251K | $3.09 | $775K | No | Form 4 ↗ |
| 2025-08-13 | 2025-08-11 | Grow Brian Chief Commercial Officer | FTax | −2.17K | $4.62 | $10.0K | No | Form 4 ↗ |
| 2025-08-13 | 2025-08-11 | Grow Brian, Chief Commercial Officer | MExercise | +4.06K | $2.47 | $10.0K | No | Form 4 ↗ |
| 2025-07-18 | 2025-07-16 | Cavorsi Robert Vice President, Strategy | FTax | −360.00 | $4.47 | $1.61K | No | Form 4 ↗ |
Insiders — a company’s officers, directors and holders of more than 10% of its stock — must report any trade in that stock to the SEC on a Form 4 within two business days. Each row here is one transaction from those filings.
The transaction code tells you what happened: Purchase (P) and Sale (S) are open-market trades — the ones markets watch most; Award (A) is a granted stock or unit, Option exercise (M) converts options into shares, and Gift (G) is a transfer for no consideration. Awards, exercises and gifts are largely compensation or administrative, not a directional bet.
One caveat on sales: many are made under a Rule 10b5-1 plan scheduled months in advance, so a sale is not automatically a bearish signal. Insider activity is a noisy input — read it alongside the filings, not on its own.
See also ORGO’s full analysis or the market-wide insider trading feed. The tabs above jump to ORGO’s other SEC data.
Source: SEC Form 4 filings for ORGO, parsed from EDGAR. Transaction prices are as reported in the filing — SEC public-domain data, not market quotes. Values are shares × reported price where both are disclosed; grants and gifts often carry no price. A delayed record of what insiders reported, not a live position or a recommendation.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.